Boehringer Ingelheim
Boehringer Ingelheim, a leading name in the pharmaceutical preparation manufacturing industry, is headquartered in Ingelheim am Rhein, Germany. Founded in 1885, the company has established a strong global presence, with significant operations across Europe, North America, and Asia.
Specialising in prescription medicines, animal health, and biopharmaceutical contract manufacturing, Boehringer Ingelheim is renowned for its innovative therapies that address unmet medical needs. The company’s commitment to research and development has led to numerous breakthroughs, particularly in respiratory diseases, oncology, and diabetes care.
With a robust portfolio of unique products and a reputation for quality, Boehringer Ingelheim consistently ranks among the top pharmaceutical companies worldwide, reflecting its dedication to improving health and well-being across diverse populations.
-1 vs industry average
Boehringer Ingelheim’s score of 37 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Boehringer Ingelheim?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Boehringer Ingelheim's reported carbon emissions
Boehringer Ingelheim, a pharmaceutical preparation manufacturer headquartered in Germany, reported its environmental performance and climate commitments.
For the reporting year 2024, the company recorded Scope 1 emissions of approximately 274,000,000 kg CO2e and Scope 2 emissions of approximately 64,000,000 kg CO2e.
In 2023, Boehringer Ingelheim's emissions were approximately 295,000,000 kg CO2e for Scope 1 and 66,000,000 kg CO2e for Scope 2. Scope 3 emissions for this year were approximately 4,043,000,000 kg CO2e. The company's total greenhouse gas emissions for 2023 were approximately 4,404,000,000 kg CO2e.
Earlier in 2022, Scope 1 emissions were approximately 280,000,000 kg CO2e, and Scope 2 emissions were approximately 71,000,000 kg CO2e. Scope 3 emissions stood at approximately 4,239,000,000 kg CO2e, making the total greenhouse gas emissions approximately 4,590,000,000 kg CO2e for that year.
In 2021, Scope 1 emissions were approximately 280,000,000 kg CO2e, Scope 2 emissions were approximately 99,000,000 kg CO2e, and Scope 3 emissions were approximately 4,081,000,000 kg CO2e. The total greenhouse gas emissions for 2021 were approximately 4,460,000,000 kg CO2e.
For 2020, Scope 1 emissions were approximately 276,000,000 kg CO2e, Scope 2 emissions were approximately 165,000,000 kg CO2e, and Scope 3 emissions were approximately 4,066,000,000 kg CO2e, resulting in total greenhouse gas emissions of approximately 4,507,000,000 kg CO2e.
In 2019, Boehringer Ingelheim reported Scope 1 emissions of approximately 289,000,000 kg CO2e, Scope 2 emissions of approximately 273,000,000 kg CO2e, and Scope 3 emissions of approximately 3,801,000,000 kg CO2e. The total greenhouse gas emissions for 2019 were approximately 4,363,000,000 kg CO2e.
Boehringer Ingelheim has made significant climate commitments. The company commits to reducing absolute Scope 1 and 2 greenhouse gas emissions by 58.9% by 2030, using 2019 as the base year. Additionally, it aims to reduce absolute Scope 3 greenhouse gas emissions from purchased goods and services, capital goods, fuel and energy-related activities, upstream transportation and distribution, and use of sold products by 27.5% within the same timeframe. These targets are aligned with a 1.5°C warming scenario.
The emissions data reported for Boehringer Ingelheim is cascaded from its parent entity, Boehringer Ingelheim GmbH, as it operates as a current subsidiary.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Boehringer Ingelheim’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Boehringer Ingelheim yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
Inherited from C.H. Boehringer Sohn AG & Co. KG
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Boehringer Ingelheim
Frequently asked questions
Common questions about Boehringer Ingelheim’s sustainability data and climate commitments
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project